Literature DB >> 8170169

The epidemiology of leukemia in Kuwait.

S al-Bahar1, R Pandita, A al-Muhannaha, E al-Bahar.   

Abstract

This study reports the occurrence of leukemia subtypes in Kuwait between 1979 and 1989. The cases were analyzed by age, sex, Kuwaiti and non-Kuwaiti nationality status. Of the total 723 cases, acute lymphoblastic leukemia (ALL) was the most frequent (44.2%), exhibited a peak incidence in the 0-4 years age group and was also the most common leukemia of childhood (90.5%). Acute myeloblastic leukemia (AML) constituted 32.4% of leukemia and showed a progressive increase in incidence with age. Chronic myeloid leukemia (CML) constituted 14.8% and chronic lymphocytic leukemia (CLL) 8.6% of all cases. The incidence, age and sex distribution of ALL, AML and CML was similar to that in the developed Western countries while the lesser frequency of CLL was similar to that in the Orient. This pattern of leukemia subtypes may be related to the population structure consisting of the predominantly young in Kuwait, and the peak incidence of ALL in the very young to the socio-economic conditions.

Entities:  

Mesh:

Year:  1994        PMID: 8170169     DOI: 10.1016/0145-2126(94)90027-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Evaluation of Prognostic Impact of Soluble CD14 in B-Chronic Lymphocytic Leukemia.

Authors:  Waiel Al-Kahiry; Homam Sharshira; Amal Ghanem; Maha El-Gammal; Irene Lewis Mikhael
Journal:  Indian J Hematol Blood Transfus       Date:  2016-11-16       Impact factor: 0.900

2.  Epidemiology of de novo Acute Myeloid Leukemia in Kuwait per the 2016 WHO Classification.

Authors:  Salem H Alshemmari; Mazyad Almazyad; Mohan Ram; Liby Mariamma John; Ahmed Alhuraiji
Journal:  Med Princ Pract       Date:  2022-04-25       Impact factor: 2.132

3.  Myeloid Leukemias: A Glance at Middle Eastern Centers.

Authors:  Safaa Aa Khaled; Ola Nabih; Nashwa M Abdel Aziz; Dalia G Mahran
Journal:  J Blood Med       Date:  2019-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.